Laura  Rubbia-Brandt is Director of the Division of Clinical Pathology, Geneva University Hospital, Switzerland, and full professor in pathology where she teaches GI and liver Pathology at Geneva Medical School. She received her medical education at the University of Geneva and her specialty training in the Division of Clinical Pathology,  Geneva  University  Hospital  Switzerland  and  Hôpital Beaujon,  Paris,  France.  She is president of the Swiss Hepato-Biliary  pathology  group, which is a section  of  the Swiss  society  of  pathology. She is also president of the Swiss society of  pathology,  an active  member  of  the board of the Swiss association for the study of the liver, referent pathologist of the Swiss Hepatitis C Cohort Study  Group,  and  member  of the  GI  pathology  group  of  the  Swiss  Institute  for  Applied  Cancer Research,. She is also a member of the Unites States and Canadian academy of pathology (USCAP), Hans Pooper Liver pathology society, and the International Academy of Pathology (IAP).   Laura Rubbia Brandt is the author of more than 200 scientific articles, book chapters and reviews. Her research interests are pathogenesis of hepatic secondary effects neoadjuvant chemotherapy in colorectal metastasis  and  mechanisms  and  role of  HCV  infection  in  the  development  of  hepatic steatosis.